BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8682957)

  • 1. Acquired ichthyosis in bone marrow transplant recipients.
    Spelman LJ; Strutton GM; Robertson IM; Weedon D
    J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
    Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
    Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.
    Baker KS; Loberiza FR; Yu H; Cairo MS; Bolwell BJ; Bujan-Boza WA; Camitta BM; Garcia JJ; Ho WG; Liesveld JL; Maharaj D; Marks DI; Schultz KR; Wiernik P; Zander AR; Horowitz MM; Keating A; Weisdorf DJ
    J Clin Oncol; 2005 Oct; 23(28):7032-42. PubMed ID: 16145067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
    Huang H; Lin M; Meng H
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
    Marra DE; McKee PH; Nghiem P
    J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry.
    Bortin MM; Horowitz MM; Gale RP
    Nat Immun Cell Growth Regul; 1988; 7(5-6):334-50. PubMed ID: 3065641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Reynaert H; De Coninck A; Neven AM; Van Camp B; Schots R
    Bone Marrow Transplant; 1992 Aug; 10(2):185-7. PubMed ID: 1388082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Tabayashi T; Yamada K; Takeuchi M
    Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast media triggering cutaneous graft-versus-host disease.
    Vavricka SR; Halter J; Furrer K; Wolfensberger U; Schanz U
    Bone Marrow Transplant; 2002 Jun; 29(11):899-901. PubMed ID: 12080354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired ichthyosis as a manifestation of acute cutaneous graft-versus-host disease.
    Huang J; Pol-Rodriguez M; Silvers D; Garzon MC
    Pediatr Dermatol; 2007; 24(1):49-52. PubMed ID: 17300650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
    Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A
    Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatologic changes associated with roquinimex immunotherapy after autologous bone marrow transplant.
    Ohsuga Y; Rowe JM; Liesveld J; Burns RP; Gaspari AA
    J Am Acad Dermatol; 2000 Sep; 43(3):437-41. PubMed ID: 10954654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
    Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M
    Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.